PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity

Siyuan Zha(XinHua Hospital), Fang Liu(North Sichuan Medical University), Qing Cao(Ministry of Education of the People's Republic of China), Zhen Li(Shanghai Jiao Tong University), Fei Wang(Chinese Academy of Sciences)
Stem Cell Research & Therapy
August 23, 2018
10.1186/s13287-018-0961-7
Cited by 50

Related Papers

Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway
|Stem Cell Research & Therapy|2020|378
miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1
|Blood|2011|272
SIRT1 Protects Against Oxidative Stress‐Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation
|Journal of Cellular Physiology|2015|122
Interplay between microRNAs and the STAT3 signaling pathway in human cancers
|Physiological Genomics|2013|106
A donor-DNA-free CRISPR/Cas-based approach to gene knock-up in rice
|Nature Plants|2021|104